Perceptive Xontogeny Venture Fund

Perceptive Xontogeny Venture Fund

New York City, New Yorkperceptivelife.com

Overview

An early-stage venture capital fund, managed as a partnership between Perceptive Advisors and Xontogeny, focused on private investments in life sciences companies. The fund primarily acts as a lead investor in Series A financings, aiming to advance products and technologies from preclinical stages through early clinical development. It is the first in a series of funds, followed by Perceptive Xontogeny Venture Fund II.

Portfolio Companies

14

Investments

CompanyDateStageLead
Mercy BioAnalyticsSep 2025Series BCo-investor
Gala TherapeuticsSep 2025Series CCo-investor
GalvanizeSep 2025Series CCo-investor
Zucara Therapeutics Inc.May 2025Series BCo-investor
Marea TherapeuticsJun 2024Series A and BCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersNew York City, New York
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.